Comparison of Segmental Longitudinal Peak Strain Values in Patients with Non-Ischemic Dilated Cardiomyopathy
SN Comprehensive Clinical Medicine, cilt.8, sa.1, 2026 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 8 Sayı: 1
- Basım Tarihi: 2026
- Doi Numarası: 10.1007/s42399-026-02703-2
- Dergi Adı: SN Comprehensive Clinical Medicine
- Derginin Tarandığı İndeksler: Scopus, EMBASE, Health Research Premium Collection (ProQuest)
- Anahtar Kelimeler: Global longitudinal strain, ICD, Non-ischemic dilated cardiomyopathy, Risk stratification, Segmental longitudinal strain, Speckle-tracking echocardiography, Ventricular arrhythmia
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Background: Implantable cardioverter-defibrillator (ICD) implantation for primary prevention in non-ischemic dilated cardiomyopathy (NI-DCM) remains debated, as a substantial proportion of recipients never experience arrhythmic events. Current risk stratification relies predominantly on left ventricular ejection fraction (LVEF), which inadequately identifies patients at true arrhythmic risk. This study evaluated the predictive value of global and segmental longitudinal strain for ventricular arrhythmic events in NI-DCM patients receiving primary prevention ICDs. Methods: This retrospective, single-center cohort study included 92 consecutive patients with NI-DCM (LVEF ≤ 40%, NYHA functional class II–III on guideline-directed medical therapy) who underwent ICD implantation for primary prevention and attended routine device follow-up. Ischemic cardiomyopathy was excluded by coronary angiography demonstrating the absence of obstructive coronary artery disease. The primary endpoint was receipt of appropriate ICD therapy (anti-tachycardia pacing [ATP] or shock) for documented ventricular tachycardia (VT) or ventricular fibrillation (VF). Speckle-tracking echocardiography (STE)-derived global longitudinal strain (GLS) and 16-segment longitudinal strain were measured prior to ICD implantation and compared between patients who experienced arrhythmic events (arrhythmia group; n = 42) and those who remained event-free (arrhythmia-free group; n = 50) over a mean follow-up of 2.4 ± 0.8 years. Results: GLS was significantly more impaired in the arrhythmia group compared to the arrhythmia-free group (–10.17 ± 4.42% vs. − 11.89 ± 3.76%; p = 0.046). Basal segmental strains showed the most prominent inter-group differences, with statistically significant impairment at the basal anterior (–10.1 ± 3.6% vs. − 12.1 ± 4.4%; p = 0.023), basal inferoseptal (median: − 7% vs. − 10%; p = 0.015), basal inferior (–9.1 ± 4.9% vs. − 10.7 ± 3.7%; p = 0.014), and basal anterolateral (median: − 9% vs. − 11%; p = 0.004) segments. ROC analysis identified a peak basal longitudinal strain cut-off of >–9.08% (absolute value < 9.08%) for predicting arrhythmic events (AUC = 0.67; sensitivity 59.5%; specificity 70.0%; p = 0.004). On multivariable Cox regression, peak basal longitudinal strain remained an independent predictor of arrhythmic events (HR 1.265; 95% CI 1.030–1.554; p = 0.025). Conclusion: Impaired basal longitudinal strain is independently associated with ventricular arrhythmic events in NI-DCM patients receiving primary prevention ICDs. Although the AUC indicates moderate discriminative performance, regional strain analysis may serve as an adjunctive risk stratification tool alongside LVEF in this population, and may help identify patients who warrant further evaluation with advanced imaging modalities.